The United States is likely to have large supplies of coronavirus vaccine(s) sometime in the next six to twelve months. Short shelf life combined with ultra-cold transportation and storage requirements will seriously constrain distribution and delivery of available supplies. We do not (yet) have effective processes for targeting real demand. We need accurate demand targeting to optimize whatever logistics capacity that can be made available.